Preview
Cognito Therapeutics presented exploratory cerebrospinal fluid proteomics data at the Alzheimer's Association International Conference 2026, from its Phase 2 FLICKER study of the investigational Spectris sensory-stimulation platform in 10 amyloid-positive…
The complete summary, “why it matters” analysis and the original source link are available to members.
NeurostimulationNeuromodulation